Introduction
Despite recent advances in multidisciplinary approaches, surgical resection remains the standard treatment for potentially resectable esophageal carcinoma. In addition to primary tumor resection, removal of all potentially involved lymph nodes is essential for achieving cure. In the present 7th UICC TNM classification [
1] and the 7th AJCC Cancer Staging manual [
2], the regional nodes are not varied irrespective of the location of the primary tumor. The extent of lymph node dissection in esophageal cancer surgery is estimated by the number of resected regional lymph nodes, irrespective of the area of dissection [
2]. However, many surgeons accept that the area of nodal dissection should be modified according to the location of the primary tumor in an individual patient.
The purpose of this retrospective study was to evaluate the efficacy of lymph node dissection by the area based on the location of the primary tumor, calculating the frequency and patient survival of metastases to the area in patients with thoracic esophageal squamous cell carcinoma who underwent esophagectomy with curative intent. This study was based on a large, multi-institutional, nationwide registry of esophageal cancer maintained by the Japan Esophageal Society.
Results
Patient characteristics and findings are listed in Table
2. The location of the tumors was the upper esophagus in 629 patients (16.4 %), the middle esophagus in 2215 (57.9 %), and the lower esophagus in 983 (25.7 %).
Table 2
Patients’ characteristics and tumor findings
Median age (range), year | 63.0 (30–85) |
Sex |
Male | 3293 (86.0 %) |
Female | 534 (14.0 %) |
Tumor location |
Upper | 983 (16.4 %) |
Middle | 2215 (57.9 %) |
Lower | 629 (25.7 %) |
Preoperative therapy |
Chemotherapy | 515 (13.5 %) |
Chemoradiotherapy | 238 (6.2 %) |
Radiotherapy | 3 (0.1 %) |
None | 3071 (80.2 %) |
Clinical T classification |
T1 | 1160 (30.3 %) |
T2 | 701 (18.3 %) |
T3 | 1810 (47.3 %) |
T4 | 156 (4.1 %) |
Pathologic positive node number (including supraclavicular node) |
N0 | 1616 (42.2 %) |
N(1–2) | 843 (22.0 %) |
N(3–6) | 903 (23.6 %) |
N(7–) | 465 (12.2 %) |
Preoperative neoadjuvant chemoradiotherapy was administered to 238 patients (6.2 %), 515 patients (13.5 %) received preoperative chemotherapy, and 3 patients (0.1 %) received preoperative radiotherapy. Preoperative therapy was under clinical study [
16] and not standard for esophageal cancer in Japan during the registration period. The selection of patients, indications, and therapeutic approach to preoperative therapy depended on each institution and were not specified.
The 30-day operative mortality rate was 0.9 % (33 patients) and 90-day mortality was 1.8 % (69 patients). The 5-year survival rate for all patients was 57.5 %.
The frequency of metastasis, the 5-year survival rate of patients with metastases, and the EI of each zone are presented according to tumor location in Table
3. The frequency of metastasis and the EI of each zone were different by tumor locations. In patients with upper esophageal tumors, the EIs of the supraclavicular zone and the upper mediastinal zone were high. In contrast, those of the middle mediastinal, lower mediastinal and perigastric zones were low. In patients with middle esophageal tumors, the EI of the upper mediastinal zone was the highest, followed by those of supraclavicular zone and perigastric zones. In patients with lower esophageal tumors, the EI of perigastric zone was the highest, followed by those of upper mediastinal and lower mediastinal zones. The EIs of celiac zone were the lowest among all the zones in patients with thoracic squamous cell carcinoma. Differences of the EIs between zones mostly depended on difference of the frequency of metastasis to zones. Differences of the 5-year survival rates of patients with metastases between zones were less.
Table 3
The frequency of metastasis, the 5-year survival rate of patients with metastases, and the EI of each zone according to tumor location for esophageal squamous cell carcinoma
Supraclavicular zone | 210 | 33.4 | 42.3 | 14.1 | 505 | 22.8 | 40.5 | 9.2 | 173 | 17.6 | 30.0 | 5.3 |
Upper mediastinal zone | 270 | 42.9 | 41.1 | 17.6 | 829 | 37.4 | 40.0 | 15.0 | 249 | 25.3 | 32.6 | 8.2 |
Middle mediastinal zone | 59 | 9.4 | 32.2 | 3.0 | 462 | 20.9 | 29.0 | 6.1 | 193 | 19.6 | 24.1 | 4.7 |
Lower mediastinal zone | 27 | 4.3 | 33.1 | 1.4 | 254 | 11.5 | 33.5 | 3.9 | 242 | 24.6 | 34.2 | 8.4 |
Perigastric zone | 62 | 9.9 | 31.1 | 3.1 | 618 | 27.9 | 33.2 | 9.3 | 479 | 48.7 | 36.5 | 17.8 |
Celiac zone | 5 | 0.8 | 0.0 | 0.0 | 89 | 4.0 | 26.1 | 1.0 | 104 | 10.6 | 27.0 | 2.9 |
The frequency of metastasis, the 5-year survival rate of patients with metastases, and the EIs of each zone in patients with cT1 tumor are presented in Table
4. In patients with upper esophageal cT1 tumors, the EI of the upper mediastinal zone was highest. However, in patients with middle and lower esophageal cT1 tumors, the EIs of the middle and lower mediastinal zones were lower than those of the upper mediastinal and perigastric zones. In 22 patients with lower esophageal cT1 tumors and metastasis to the supraclavicular zone, 9 patients had the proximal margin of the tumor in the middle esophagus. In 27 patients with lower esophageal cT1 tumors and metastasis to the upper mediastinal zone, 14 patients had the proximal margin of the tumor in the middle esophagus.
Table 4
The frequency of metastasis, the 5-year survival rate of patients with metastases, and the EI of each zone according to tumor location for cT1 esophageal squamous cell carcinoma
Supraclavicular zone | 42 | 19.9 | 60.7 | 12.1 | 94 | 12.5 | 58.9 | 7.4 | 22 | 11.2 | 39.4 | 4.4 |
Upper mediastinal zone | 56 | 26.5 | 62.8 | 16.6 | 161 | 21.4 | 57.5 | 12.3 | 27 | 13.7 | 58.2 | 8.0 |
Middle mediastinal zone | 2 | 0.9 | 50.0 | 0.5 | 32 | 4.3 | 34.4 | 1.5 | 12 | 6.1 | 22.2 | 1.4 |
Lower mediastinal zone | 2 | 0.9 | 0.0 | 0.0 | 30 | 4.0 | 66.9 | 2.7 | 17 | 8.6 | 46.3 | 4.0 |
Perigastric zone | 8 | 3.8 | 15.0 | 0.6 | 76 | 10.1 | 53.9 | 5.4 | 34 | 17.3 | 45.2 | 7.8 |
Celiac zone | 0 | 0.0 | | | 11 | 1.5 | 36.4 | 0.5 | 5 | 2.5 | | |
The frequency of metastasis, the 5-year survival rate of patients with metastases, and the EIs of each zone in patients with cT2-4 tumors are presented in Table
5. In patients with middle esophageal cT2-4 tumors, frequency of lymph node metastasis and the EI of the middle mediastinal zone was increased dramatically compared with patients with cT1 tumors, but still lower than those of the upper mediastinal and perigastric zones. In patients with lower esophageal cT2-4 tumors, the EI of the upper mediastinal zones was as high as that of the lower mediastinal zones.
Table 5
The frequency of metastasis, the 5-year survival rate of patients with metastases, and the EI of each zone according to tumor location for cT2-4 esophageal squamous cell carcinoma
Supraclavicular zone | 168 | 40.2 | 37.8 | 15.2 | 411 | 28.1 | 36.6 | 10.3 | 151 | 19.2 | 27.7 | 5.3 |
Upper mediastinal zone | 214 | 51.2 | 34.6 | 17.7 | 668 | 45.7 | 36.2 | 16.5 | 222 | 28.2 | 27.8 | 7.8 |
Middle mediastinal zone | 57 | 13.6 | 31.8 | 4.3 | 430 | 29.4 | 28.4 | 8.3 | 181 | 23.0 | 23.8 | 5.5 |
Lower mediastinal zone | 25 | 6.0 | 34.5 | 2.1 | 224 | 15.3 | 28.9 | 4.4 | 225 | 28.6 | 33.2 | 9.5 |
Perigastric zone | 54 | 12.9 | 33.8 | 4.4 | 542 | 37.0 | 30.3 | 11.2 | 445 | 56.6 | 35.7 | 20.2 |
Celiac zone | 5 | 1.2 | 0.0 | 0.0 | 78 | 5.3 | 24.6 | 1.3 | 99 | 12.6 | 25.3 | 3.2 |
Discussion
The present study showed that the efficacies of node dissection differed by zone of lymph node. Many previous studies demonstrated that the number of lymph nodes removed is an independent predictor of survival after esophagectomy for cancer [
17‐
22]. The extent of lymph node dissection in esophageal cancer surgery was estimated by the number of resected regional lymph nodes. In the present 7th UICC TNM Classification, it is recommended that histological examination of a regional lymphadenectomy specimen ordinarily include 7 or more lymph nodes [
1]. The 7th AJCC staging manual recommends that, for pT1, approximately 10 nodes must be resected to maximize survival; for pT2, 20 nodes; and for pT3 or pT4, 30 nodes or more [
2], based on the data of the worldwide esophageal cancer collaboration [
22]. In NCCN guideline, in patients undergoing esophagectomy without induction chemoradiation, at least 15 lymph nodes should be removed to achieve adequate nodal staging [
23]. However, when only the node zones with low EI are dissected, and those with high EI are not dissected, the efficacy of node dissection is low, even more than 20 nodes are dissected. Thus, the effective extent of node dissection should be modified by the EIs of node zones.
EIs of each node zone were differed by tumor location. The zones for dissection should be modified according to the location of the tumor. For upper esophageal tumors, the upper mediastinal zone had the highest EI and is the most important dissection target. The EI of supraclavicular zone was also high and supraclavicular node dissection is indispensable for patients with upper esophageal tumor. Supraclavicular nodes should be classified as regional nodes for tumors in the upper esophagus. In patients with tumor in the middle esophagus, upper mediastinal zone had the highest EI followed by perigastric and supraclavicular zones. For patients with tumor in the middle esophagus, the most common type of esophageal tumor in Asia, not only mediastinal and abdominal, but also cervical dissection by the three-field approach is recommended. Patients with tumor in the lower esophagus had the highest EI in perigastric zone. However, the EI of upper mediastinal zone was as high as that of lower mediastinal zone. Upper mediastinal dissection is recommended for all patients with thoracic esophageal squamous cell carcinoma, irrespective of the location.
The present study showed that the frequency of metastasis and the EI did not reflect the anatomical distance from the primary tumor, but rather the lymphatic drainage system reported previously [
24,
25]. Even with tumors located in the middle and lower esophagus, lymphatic metastasis was frequent in the upper mediastinal and perigastric zones. The conventional hypothesis is that tumor cells involve the nearby nodes first, then spread to nodes a little further, and finally reach distant nodes. The extent of node dissection has been estimated by anatomical distance from the primary tumor to the dissected node area. However, in patients with middle and lower esophageal cT1 tumors, the EIs of the middle and lower mediastinal zone were lower than those of upper mediastinal zone and perigastric zone. Therefor extent of dissection in patients with cT1 tumors should be not tailored according to the anatomical distance from the tumor, but according to the EI.
Many patients with lower esophageal cT1 tumors and the proximal margin of the tumor in the middle esophagus had metastasis to the supraclavicular zone and the upper mediastinal zone. It suggests that the proximal nodal spread to the supraclavicular and upper mediastinal nodes is reflect to the location of proximal margin of the tumor. The attention to the proximal margin of tumor should be paid in planning the extend of node dissection. The proximal margin of squamous cell carcinoma tends to be more proximal than those of adenocarcinoma. Supraclavicular and upper mediastinal node metastasis are not neglected.
In this study, lymph node stations were classified into lymph node zones according to the map in AJCC Staging Manual. In surgical dissection and in identification and labeling during pathological examination of specific lymph node, and also in planning of irradiation field, lymph node zones are more practical than small neighboring lymph node stations.
The present study was based on patients with squamous cell carcinoma, and patients with adenocarcinoma were not included. However, in Asian patients, including Japanese patients, squamous cell carcinoma remains the predominant histological cell type of esophageal cancer, and more than half of tumors locates in the upper and middle esophagus.
In conclusion, the EIs of each zone were differed by tumor location. The extent of lymph node dissection should be estimated by the dissected lymph node zones and modified by the tumor location. Supraclavicular dissection is indispensable for patients with upper esophageal tumors and recommended for patients with middle esophageal tumors. Upper mediastinal dissection is recommended for all patients with thoracic esophageal squamous cell carcinoma, irrespective of the location.
Acknowledgments
This registry complies with the Act for the Protection of Personal Information that was promulgated in 2003, and follows the ethical guidelines for epidemiologic studies published jointly by the Japan Ministry of Education, Culture, Sports, Science and Technology and the Japan Ministry of Health, Labour, and Welfare in 2002, which was revised in 2007. This study was supported by Health and Labour Sciences Research Grants for Promotion of Cancer Control Programs (H26-Cancer Policy-General-014) from the Ministry of Health, Labour, and Welfare of Japan. The authors were members of the Registration Committee for Esophageal Cancer, the Japan Esophageal Society, and made great contributions to the preparation of this material.